Posted On: 07/15/2014 1:35:01 PM
Post# of 63824
$CDXS gap Pr after hours $1.94
REDWOOD CITY, Calif., July 14, 2014 (GLOBE NEWSWIRE)
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts
for the pharmaceutical and fine chemical industries, today announced
the signing of a platform technology license agreement with GlaxoSmithKline
(GSK). ] news release
Website
recent trades
10-Q 5/8/14
O/S shares 38,660,773
REDWOOD CITY, Calif., July 14, 2014 (GLOBE NEWSWIRE)
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts
for the pharmaceutical and fine chemical industries, today announced
the signing of a platform technology license agreement with GlaxoSmithKline
(GSK). ] news release
Website
recent trades
10-Q 5/8/14
O/S shares 38,660,773
(0)
(0)
